Fresenius Medical Cash And Equivalents vs. Current Valuation

FMS Stock  USD 23.65  0.04  0.17%   
Taking into consideration Fresenius Medical's profitability measurements, Fresenius Medical Care is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in January. Profitability indicators assess Fresenius Medical's ability to earn profits and add value for shareholders.
 
Cash And Equivalents  
First Reported
2010-12-31
Previous Quarter
326.5 M
Current Value
422 M
Quarterly Volatility
253.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 0.28 in 2024. Days Sales Outstanding is likely to drop to 63.33 in 2024. At this time, Fresenius Medical's Net Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 357.8 M in 2024, whereas Operating Income is likely to drop slightly above 1.3 B in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.360.2532
Significantly Up
Slightly volatile
Net Profit Margin0.04560.0257
Way Up
Slightly volatile
Pretax Profit Margin0.080.0531
Way Up
Slightly volatile
Return On Assets0.0140.0147
Notably Down
Slightly volatile
Return On Equity0.07270.0366
Way Up
Slightly volatile
For Fresenius Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fresenius Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fresenius Medical Care utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fresenius Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fresenius Medical Care over time as well as its relative position and ranking within its peers.
  

Fresenius Medical's Revenue Breakdown by Earning Segment

Check out Investing Opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.525
Dividend Share
1.19
Earnings Share
1.18
Revenue Per Share
32.785
Quarterly Revenue Growth
(0.04)
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Fresenius Medical Care Current Valuation vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth.
Fresenius Medical Care is rated below average in cash and equivalents category among its peers. It is rated as one of the top companies in current valuation category among its peers reporting about  69.57  of Current Valuation per Cash And Equivalents. At this time, Fresenius Medical's Cash And Equivalents is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Fresenius Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Fresenius Current Valuation vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Fresenius Medical

Cash

 = 

Bank Deposits

+

Liquidities

 = 
362.77 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Fresenius Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
25.24 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Fresenius Current Valuation vs Competition

Fresenius Medical Care is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 249.46 Billion. Fresenius Medical retains roughly 25.24 Billion in current valuation claiming about 10% of equities under Health Care industry.

Fresenius Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Fresenius Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fresenius Medical will eventually generate negative long term returns. The profitability progress is the general direction of Fresenius Medical's change in net profit over the period of time. It can combine multiple indicators of Fresenius Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-975.2 M-926.4 M
Operating Income1.4 B1.3 B
Net Income732.5 M857.9 M
Income Tax Expense300.6 M357.8 M
Income Before TaxB1.2 B
Total Other Income Expense Net-336.4 M-319.6 M
Net Income Applicable To Common Shares774.4 M931.7 M
Net Income From Continuing Ops732.5 M1.1 B
Interest Income88.2 M83.8 M
Net Interest Income-336.4 M-353.2 M
Change To Netincome-88.3 M-83.9 M
Net Income Per Share 1.70  1.10 
Income Quality 3.59  2.54 
Net Income Per E B T 0.48  0.46 

Fresenius Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Fresenius Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fresenius Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fresenius Medical's important profitability drivers and their relationship over time.

Use Fresenius Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fresenius Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresenius Medical will appreciate offsetting losses from the drop in the long position's value.

Fresenius Medical Pair Trading

Fresenius Medical Care Pair Trading Analysis

The ability to find closely correlated positions to Fresenius Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fresenius Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fresenius Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fresenius Medical Care to buy it.
The correlation of Fresenius Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fresenius Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fresenius Medical Care moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fresenius Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Fresenius Medical position

In addition to having Fresenius Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs
Volatility ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.